COM:FARON
Faron Pharmaceuticals Ltd.
- Stock
Last Close
142.50
22/11 14:00
Market Cap
1.36M
Beta: -
Volume Today
20.05K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -1.51M - | -1.36M 9.55% | -6.14M 350.44% | -9.29M 51.27% | -21.06M 126.60% | -20.08M 4.63% | -13.25M 34.02% | -16.94M 27.81% | -21.19M 25.14% | -28.73M 35.56% | -30.94M 7.71% | |
depreciation and amortization | 56K - | 60K 7.14% | 184K 206.67% | 168K 8.70% | 76K 54.76% | 100K 31.58% | 238K 138% | 283K 18.91% | 307K 8.48% | 300K 2.28% | 346K 15.33% | |
deferred income tax | -285K - | -360K 26.32% | 279K 177.50% | -65K 123.30% | -56K 13.85% | 98K 275% | 114K 16.33% | -1.25M - | ||||
stock based compensation | 430K - | 480K 11.63% | 1.19M 147.71% | -176K 114.80% | 51K 128.98% | 386K 656.86% | 1.49M 285.23% | 1.30M 12.78% | 2.45M 88.90% | |||
change in working capital | 694K - | 916K 31.99% | -1.71M 286.35% | 193K 111.31% | 1.08M 458.55% | -421K 139.05% | 1.34M 417.58% | -872K 165.22% | -1.76M 101.95% | 4.77M 370.64% | 3.24M 31.93% | |
accounts receivables | ||||||||||||
inventory | -553K - | 400K 172.33% | 50K 87.50% | -802K 1,704% | ||||||||
accounts payables | ||||||||||||
other working capital | 1.25M - | 516K 58.62% | -1.76M 440.50% | 995K 156.63% | ||||||||
other non cash items | -10K - | -1K 90% | 376K 37,700% | 361K 3.99% | 75K 79.22% | 121K 61.33% | 158K 30.58% | -438K 377.22% | -1.17M 167.35% | -626K 46.54% | 1.10M 275.40% | |
net cash provided by operating activities | -768K - | -389K 49.35% | -7.15M 1,737.02% | -8.45M 18.28% | -18.36M 117.26% | -20.52M 11.77% | -11.52M 43.86% | -17.48M 51.69% | -22.22M 27.11% | -22.99M 3.49% | -23.81M 3.54% | |
investments in property plant and equipment | -73K - | -151K 106.85% | -107K 29.14% | -92K 14.02% | -98K 6.52% | -295K 201.02% | -100K 66.10% | -142K 42% | -474K 233.80% | -385K 18.78% | -123K 68.05% | |
acquisitions net | ||||||||||||
purchases of investments | ||||||||||||
sales maturities of investments | ||||||||||||
other investing activites | 1K - | |||||||||||
net cash used for investing activites | -73K - | -151K 106.85% | -107K 29.14% | -92K 14.02% | -98K 6.52% | -295K 201.02% | -100K 66.10% | -142K 42% | -473K 233.10% | -385K 18.60% | -123K 68.05% | |
debt repayment | -434K - | -343K 20.97% | -151K - | -84K 44.37% | -347K 313.10% | -151 99.96% | -122K 80,694.70% | -122K 0% | -105K 13.93% | -861K 720% | ||
common stock issued | 1.27M - | 1.13M 11.76% | 18.08M 1,507.11% | 8.52M 52.88% | 17.36M 103.80% | 17.02M 1.95% | 15.63M 8.20% | 14.10M 9.75% | 25.56M 81.23% | 13.45M 47.40% | 26.03M 93.61% | |
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 587K - | -695K 218.40% | -1.14M 63.31% | -1.02M 10.23% | 806K 179.11% | 153K 81.02% | 10.14M 6,526.14% | 81K 99.20% | ||||
net cash used provided by financing activities | 841K - | 782K 7.02% | 18.08M 2,212.02% | 8.96M 50.47% | 16.58M 85.18% | 15.54M 6.28% | 14.61M 6.00% | 14.79M 1.23% | 25.59M 73.06% | 23.48M 8.25% | 23.98M 2.15% | |
effect of forex changes on cash | -1K - | -1K 0% | -290K 28,900% | 36K 112.41% | 7K 80.56% | -117K 1,771.43% | -153K 30.77% | 37K 124.18% | -168K 554.05% | |||
net change in cash | 242K - | 10.83M 4,373.55% | 410K 96.21% | -2.17M 628.78% | -5.24M 141.84% | 2.99M 157.07% | -2.95M 198.63% | 2.75M 193.02% | 137K 95.01% | -114K 183.21% | ||
cash at beginning of period | 242K - | 11.07M 4,473.55% | 11.48M 3.70% | 9.31M 18.89% | 4.07M 56.32% | 7.06M 73.57% | 4.11M 41.80% | 6.85M 66.82% | 6.99M 2.00% | |||
cash at end of period | 242K - | 11.07M 4,473.55% | 11.48M 3.70% | 9.31M 18.89% | 4.07M 56.32% | 7.06M 73.57% | 4.11M 41.80% | 6.85M 66.82% | 6.99M 2.00% | 6.88M 1.63% | ||
operating cash flow | -768K - | -389K 49.35% | -7.15M 1,737.02% | -8.45M 18.28% | -18.36M 117.26% | -20.52M 11.77% | -11.52M 43.86% | -17.48M 51.69% | -22.22M 27.11% | -22.99M 3.49% | -23.81M 3.54% | |
capital expenditure | -73K - | -151K 106.85% | -107K 29.14% | -92K 14.02% | -98K 6.52% | -295K 201.02% | -100K 66.10% | -142K 42% | -474K 233.80% | -385K 18.78% | -123K 68.05% | |
free cash flow | -841K - | -540K 35.79% | -7.25M 1,243.15% | -8.54M 17.80% | -18.46M 116.07% | -20.82M 12.78% | -11.62M 44.17% | -17.62M 51.60% | -22.69M 28.78% | -23.38M 3.02% | -23.93M 2.36% |
All numbers in GBP (except ratios and percentages)